Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients
On Sept. 25, 2025, Final data from a landmark clinical trial in patients with an aggressive form of…
Biolinq Shine™ Granted De Novo Classification by U.S. FDA for the First Fully Autonomous, Needle-Free Glucose Sensor
On Sept. 25, 2025, Biolinq, a pioneering developer of precision multi-analyte biosensors to improve metabolic health, announced the…
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
On Sept. 24, 2025, Sanofi Ventures has announced an additional $625 million multi-year capital commitment from Sanofi, increasing…
Gene therapy appears to slow Huntington’s disease progression
On Sept. 24, 2025, a global clinical trial for a new Huntington’s disease treatment has posted positive results,…
Biodiversity Cell Atlas: mapping the tree of life at cellular resolution
On Sept. 24, 2025, an ambitious and revolutionary initiative aims to map every cell of all eukaryotic life…
Biotechnology | HIV | Vaccine | WHO
Indian drugmakers Dr Reddy’s, Hetero to sell generic HIV prevention drug for $40 a year
On Sept. 24, 2025, Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs announced they will sell generic versions…
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
Variational AI Enters $349 Million Collaboration with Merck to Apply Generative AI to Drug Discovery
On Sept. 23, 2025, Variational AI a generative AI drug discovery company, announced a collaboration with Merck to…
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio for $4.9 billion
On Sept. 22, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
Bill Gates pledges $912 million to global disease fight, urges governments to step up
On Sept. 22, 2025, The Gates Foundation will give $912 million to the Global Fund to Fight AIDS,…
Over 400,000 turkeys euthanized in South Dakota due to bird flu
On Sept. 22, 2025, the U.S. Department of Agriculture (USDA) reported that over 400,000 turkeys have been euthanized…
Biotechnology | CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Measles | NIH | Polio | Vaccine | Women's Health
CDPH and West Coast Health Alliance Release Statement Responding to ACIP Updates to National Vaccine Recommendations
On Sept. 19, 2025, the state health officials of the members of the West Coast Health Alliance, including…
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH | Vaccine
Kennedy’s vaccine advisers change COVID shot guidance, calling them an individual choice
On Sept. 19, 2025, Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers added confusion to this fall’s…
The tale of the creature with the most chromosomes
On Sept. 19, 2025, researchers at the Wellcome Sanger Institute and the Institute of Evolutionary Biology, Barcelona reported…
Biogen to Acquire Alcyone Therapeutics for $85 million, Expanding Drug Delivery Solution Portfolio
On Sept. 18, 2025, Biogen announced it has has entered into a definitive agreement to acquire Massachusetts-based Alcyone…
Roche to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH for US $3.5 billion
On Sept. 17, 2025, Roche announced that it has entered into a definitive merger agreement to acquire 89bio,…
GSK to invest $30 billion in R&D and Manufacturing in the U.S. over next 5 years
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill) delivered 16.6% weight loss in people with obesity in a newly published study
On Sept. 17, 2025, The New England Journal of Medicine published the results from the OASIS 4 phase…
Lilly announces plans to build $5 billion manufacturing facility in Virginia
On Sept. 16, 2025, Eli Lilly announced that it plans to build a $5 billion manufacturing facility just…
New University of Alberta health institute will help research breakthroughs reach patients sooner
On Sept. 15, 2025, the University of Alberta (U of A) announced the Dianne and Irving Kipnes Health…
Biotechnology | Disease | FDA | Therapeutics
Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease
On Sept. 15, 2025, Corstasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved ENBUMYST™…
Ebola vaccination begins in the Democratic Republic of the Congo
On Sept. 14, 2025, the World Health Organization announced that vaccination of frontline health workers and contacts of…
gene therapy offers hope for genetic hearing loss
On Sept. 14, 2025, scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University…
Corn diseases lurk in bumper US crop, threatening yields
On Sept. 12, 2025, high levels of fungal disease are lurking in corn fields across the U.S. Midwest,…
3D bioprinted mini placentas could transform pregnancy research
On Sept. 12, 2025, scientists from the University of Technology Sydney (UTS) announced they have achieved a major…
Melinda French Gates launches $100 million push for women’s health research
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
Merck to scrap London drug research centre
On Sept. 10, 2025, Merck announced it was scrapping research operations in London, citing the UK’s challenging business…
Utah Health Officials Report Large Measles Exposure
On Sept. 10, 2025, the Utah Department of Health and Human Services (UDOH) reported a potential large exposure…
UK trial launches to transform Alzheimer’s diagnosis with simple blood test
On Sept. 10, 2025, a major University of London (UCL)-led clinical trial, aiming to transform the diagnosis of…
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
On Sept. 10, 2025, Exact Sciences announced the launch of the Cancerguard™ test, a new multi-cancer early detection…